Sec Form 13D Filing - W Capital Partners III, L.P. filing for Inspirato Incorporated (ISPO) - 2024-10-17

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D

 
W Capital Partners III, L.P.
 
Signature:By WCP GP III, LP its General Partner, WCP GP III, LLC its General Partner and by Peter Sala
Name/Title:Chief Financial Officer
Date:10/17/2024
 
W Capital Management, LLC
 
Signature:David Wachter
Name/Title:Chief Executive Officer
Date:10/17/2024
 
AXA IM US Group Holding Inc.
 
Signature:Jean Christophe Menioux
Name/Title:Chairman of the Board and Director
Date:10/17/2024
 
AXA Investment Managers S.A.
 
Signature:Anthony Gilsoul
Name/Title:Attorney-in-fact, duly authorized under Power of Attorney effective as of February 9th, 2023 by and on behalf of AXA Investment Managers S.A.
Date:10/17/2024
 
AXA S.A.
 
Signature:Anthony Gilsoul
Name/Title:Attorney-in-Fact, duly authorized under Power of Attorney effective as of October 15th, 2020 by and on behalf of AXA S.A.
Date:10/17/2024
primary_doc.xml